Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Clin Exp Immunol ; 173(2): 355-64, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23607364

RESUMEN

Haematopoietic humanization of mice is used frequently to study the human immune system and its reaction upon experimental intervention. Immunocompromised non-obese diabetic (NOD)-Rag1(-/-) mice, additionally deficient for the common gamma chain of cytokine receptors (γc) (NOD-Rag1(-/-) γc(-/-) mice), lack B, T and natural killer (NK) cells and allow for efficient human peripheral mononuclear cell (PBMC) engraftment. However, a major experimental drawback for studies using these mice is the rapid onset of graft-versus-host disease (GVHD). In order to elucidate the contribution of the xenogenic murine major histocompatibility complex (MHC) class II in this context, we generated immunodeficient mice expressing human MHC class II [human leucocyte antigen (HLA)-DQ8] on a mouse class II-deficient background (Aß(-/-) ). We studied repopulation and onset of GVHD in these mouse strains following transplantation of DQ8 haplotype-matched human PBMCs. The presence of HLA class II promoted the repopulation rates significantly in these mice. Virtually all the engrafted cells were CD3(+) T cells. The presence of HLA class II did not advance B cell engraftment, such that humoral immune responses were undetectable. However, the overall survival of DQ8-expressing mice was prolonged significantly compared to mice expressing mouse MHC class II molecules, and correlated with an increased time span until onset of GVHD. Our data thus demonstrate that this new mouse strain is useful to study GVHD, and the prolonged animal survival and engraftment rates make it superior for experimental intervention following PBMC engraftment.


Asunto(s)
Enfermedad Injerto contra Huésped/inmunología , Leucocitos Mononucleares/citología , Linfocitos T/inmunología , Traslado Adoptivo , Animales , Linfocitos B/inmunología , Progresión de la Enfermedad , Antígenos HLA-DQ/genética , Antígenos de Histocompatibilidad Clase II/genética , Proteínas de Homeodominio/genética , Humanos , Inmunidad Humoral/genética , Huésped Inmunocomprometido , Subunidad gamma Común de Receptores de Interleucina/genética , Leucocitos Mononucleares/trasplante , Ratones , Ratones Endogámicos NOD , Ratones Noqueados , Ratones Transgénicos
2.
Allergy ; 68(8): 1021-8, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23909913

RESUMEN

BACKGROUND: Modified vaccinia virus Ankara (MVA)-encoding antigens are considered as safe vaccine candidates for various infectious diseases in humans. Here, we investigated the immune-modulating properties of MVA-encoding ovalbumin (MVA-OVA) on the allergen-specific immune response. METHODS: The immune-modulating properties of MVA-OVA were investigated using GM-CSF-differentiated BMDCs from C57BL/6 mice. OVA expression upon MVA-OVA infection of BMDCs was monitored. Activation and maturation markers on viable MVA-OVA-infected mDCs were analyzed by flow cytometry. Secretion of INF-γ, IL-2, and IL-10 was determined in a co-culture of BMDCs infected with wtMVA or MVA-OVA and OVA-specific OT-I CD8(+) and OT-II CD4(+ ) T cells. BALB/c mice were vaccinated with wtMVA, MVA-OVA, or PBS, sensitized to OVA/alum and challenged with a diet containing chicken egg white. OVA-specific IgE, IgG1, and IgG2a and cytokine secretion from mesenteric lymph node (MLN) cells were analyzed. Body weight, body temperature, food uptake, intestinal inflammation, and health condition of mice were monitored. RESULTS: Infection with wtMVA and MVA-OVA induced comparable activation of mDCs. MVA-OVA-infected BMDCs expressed OVA and induced enhanced IFN-γ and IL-2 secretion from OVA-specific CD8(+ ) T cells in comparison with OVA, wtMVA, or OVA plus wtMVA. Prophylactic vaccination with MVA-OVA significantly repressed OVA-specific IgE, whereas OVA-specific IgG2a was induced. MVA-OVA vaccination suppressed TH 2 cytokine production in MLN cells and prevented the onset of allergic symptoms and inflammation in a mouse model of OVA-induced intestinal allergy. CONCLUSION: Modified vaccinia virus Ankara-ovalbumin (MVA-OVA) vaccination induces a strong OVA-specific TH 1- immune response, likely mediated by the induction of IFN-γ and IgG2a. Finally, MVA-based vaccines need to be evaluated for their therapeutic potential in established allergy models.


Asunto(s)
Alérgenos/inmunología , Hipersensibilidad a los Alimentos/inmunología , Hipersensibilidad a los Alimentos/prevención & control , Inmunoterapia Adoptiva/métodos , Mucosa Intestinal/inmunología , Virus Vaccinia/inmunología , Vacunas Virales/inmunología , Alérgenos/genética , Alérgenos/uso terapéutico , Animales , Trasplante de Médula Ósea/métodos , Células Cultivadas , Técnicas de Cocultivo , Células Dendríticas/inmunología , Células Dendríticas/trasplante , Células Dendríticas/virología , Modelos Animales de Enfermedad , Hipersensibilidad a los Alimentos/genética , Inflamación/inmunología , Inflamación/prevención & control , Inflamación/virología , Mucosa Intestinal/patología , Mucosa Intestinal/virología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ovalbúmina/genética , Ovalbúmina/inmunología , Ovalbúmina/uso terapéutico , Células TH1/inmunología , Células TH1/metabolismo , Células TH1/virología , Vacunas Sintéticas/genética , Vacunas Sintéticas/inmunología , Vacunas Sintéticas/uso terapéutico , Vaccinia/genética , Vaccinia/inmunología , Vaccinia/patología , Virus Vaccinia/genética , Vacunas Virales/genética , Vacunas Virales/uso terapéutico
3.
Pharmeur Bio Sci Notes ; 2022: 10-21, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35384837

RESUMEN

Human immunoglobulin products are used for the treatment of a number of diseases, such as primary or secondary immunodeficiencies and autoimmune conditions due to the complete absence of antibodies or the production of defective immunoglobulins. Quality control of human immunoglobulin products is essential to ensure therapeutic functionality and safety. This includes testing for Fc function and anticomplementary activity (ACA), as well as verification of appropriate molecular size distribution using size-exclusion chromatography as prescribed in the European Pharmacopoeia (Ph. Eur.) monographs 0338, 0918, 2788 and 1928. To this end, specific biological reference preparations (BRPs) must be used. Stocks of the Ph. Eur. Human immunoglobulin for anticomplementary activity BRP were running low and therefore a collaborative study was run by the European Directorate for the Quality of Medicines & HealthCare (EDQM), under the aegis of the Biological Standardisation Programme, to calibrate replacement batches. Six laboratories, including manufacturers and one Official Medicines Control Laboratory, took part in the study. Several batches of candidate BRPs were calibrated against Ph. Eur. Human immunoglobulin for anticomplementary activity BRP batch 2 to ensure continuity. Based on the study results, the candidate BRPs were adopted by the Ph. Eur. Commission as Ph. Eur. human immunoglobulin for anticomplementary activity BRP batch 3, 4, 5 and 6.


Asunto(s)
Inmunoglobulinas , Laboratorios , Cromatografía en Gel , Europa (Continente) , Humanos , Control de Calidad , Estándares de Referencia
4.
Thromb Haemost ; 114(2): 268-76, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25947149

RESUMEN

Treatment of haemophilia A by infusions of the clotting factor VIII (FVIII) results in the development of inhibitors/anti-drug antibodies in up to 25 % of patients. Mechanisms leading to immunogenicity of FVIII products are not yet fully understood. Amongst other factors, danger signals as elicited upon infection or surgery have been proposed to play a role. In the present study, we focused on effects of danger signals on maturation and activation of dendritic cells (DC) in the context of FVIII application. Human monocyte-derived DC were treated with FVIII alone, with a danger signal alone or a combination of both. By testing more than 60 different healthy donors, we show that FVIII and the bacterial danger signal lipopolysaccharide synergise in increasing DC activation, as characterised by increased expression of co-stimulatory molecules and secretion of pro-inflammatory cytokines. The degree and frequency of this synergistic activation correlate with CD86 expression levels on immature DC prior to stimulation. In our assay system, plasma-derived but not recombinant FVIII products activate human DC in a danger signal-dependent manner. Further tested danger signals, such as R848 also induced DC activation in combination with FVIII, albeit not in every tested donor. In our hands, human DC but not human B cells or macrophages could be activated by FVIII in a danger signal-dependent manner. Our results suggest that immunogenicity of FVIII is a result of multiple factors including the presence of danger, predisposition of the patient, and the choice of a FVIII product for treatment.


Asunto(s)
Células Dendríticas/efectos de los fármacos , Factor VIII/farmacología , Hemofilia A/tratamiento farmacológico , Adolescente , Adulto , Anciano , Linfocitos B/efectos de los fármacos , Antígeno B7-2/análisis , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Citocinas/metabolismo , Células Dendríticas/citología , Células Dendríticas/metabolismo , Sinergismo Farmacológico , Factor VIII/inmunología , Factor VIII/aislamiento & purificación , Factor VIII/uso terapéutico , Femenino , Hemofilia A/inmunología , Humanos , Imidazoles/farmacología , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Masculino , Persona de Mediana Edad , Monocitos/efectos de los fármacos , Plasma , Proteínas Recombinantes/farmacología , Proteínas Recombinantes/uso terapéutico , Adulto Joven
5.
J Cell Sci ; 114(Pt 21): 3873-84, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11719554

RESUMEN

ARVCF, a member of the catenin family, is thought to contribute to the morphoregulatory function of the cadherin-catenin complex. Recently, we reported the isolation and characterisation of murine ARVCF (mARVCF), particularly its interaction with M-cadherin. Here, we describe the identification of novel mARVCF isoforms that arise by alternative splicing. At the N-terminus, alternative splicing results in the inclusion or omission of a coiled-coil region probably important for protein-protein interactions. At the C-terminus, four isoforms also differ by domains potentially important for selective protein-protein interaction. The eight putative mARVCF isoforms were expressed as EGFP-fusion proteins in six different cell lines that exhibit a distinct pattern of cadherins. Apparently, binding of the mARVCF isoforms to M-, N-, or E-cadherin is generally unaffected by their altered N- and C-termini, as revealed by the MOM recruitment assay. However, mARVCF isoforms reproducibly exhibit differential localisation in distinct cellular environments. For example, mARVCF isoforms are unable to colocalise with N-cadherin in EJ28 carcinoma cells but do so in HeLa cells. Our results suggest that the subcellular localisation of mARVCF may be determined not only by the presence or absence of an appropriate interaction partner, in this case cadherins, but also by the cellular context.


Asunto(s)
Empalme Alternativo , Cadherinas/metabolismo , Moléculas de Adhesión Celular/metabolismo , Fosfoproteínas/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas del Dominio Armadillo , Células COS , Moléculas de Adhesión Celular/genética , Chlorocebus aethiops , Clonación Molecular , Expresión Génica , Células HeLa , Humanos , Ratones , Datos de Secuencia Molecular , Fosfoproteínas/genética , Unión Proteica , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Homología de Secuencia de Aminoácido , Células Tumorales Cultivadas
6.
J Cell Sci ; 113 ( Pt 22): 4121-35, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11058098

RESUMEN

The cytoplasmic domain of the transmembrane protein M-cadherin is involved in anchoring cytoskeletal elements to the plasma membrane at cell-cell contact sites. Several members of the armadillo repeat protein family mediate this linkage. We show here that ARVCF, a member of the p120 (ctn) subfamily, is a ligand for the cytoplasmic domain of M-cadherin, and characterize the regions involved in this interaction in detail. Complex formation in an in vivo environment was demonstrated in (1) yeast two-hybrid screens, using a cDNA library from differentiating skeletal muscle and part of the cytoplasmic M-cadherin tail as a bait, and (2) mammalian cells, using a novel experimental system, the MOM recruitment assay. Immunoprecipitation and in vitro binding assays confirmed this interaction. Ectopically expressed EGFP-ARVCF-C11, an N-terminal truncated fragment, targets to junctional structures in epithelial MCF7 cells and cardiomyocytes, where it colocalizes with the respective cadherins, beta-catenin and p120 (ctn). Hence, the N terminus of ARVCF is not required for junctional localization. In contrast, deletion of the four N-terminal armadillo repeats abolishes this ability in cardiomyocytes. Detailed mutational analysis revealed the armadillo repeat region of ARVCF as sufficient and necessary for interaction with the 55 membrane-proximal amino acids of the M-cadherin tail.


Asunto(s)
Cadherinas/metabolismo , Moléculas de Adhesión Celular/química , Moléculas de Adhesión Celular/metabolismo , Uniones Intercelulares/fisiología , Músculos/fisiología , Músculos/ultraestructura , Fosfoproteínas/química , Fosfoproteínas/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas del Dominio Armadillo , Sitios de Unión , Cadherinas/química , Membrana Celular/fisiología , Membrana Celular/ultraestructura , Células Cultivadas , Ventrículos Cardíacos , Humanos , Uniones Intercelulares/ultraestructura , Ligandos , Ratones , Datos de Secuencia Molecular , Músculos/citología , Miocardio/ultraestructura , Proteínas Recombinantes/metabolismo , Secuencias Repetitivas de Aminoácido , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA